House lawmakers voted 366-34 to pass a spending bill on Friday. The Senate passed it on a 85-11 vote. The bill, which funds ...
To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to ...
The package was supposed to hitch a ride on a year-end government funding bill that needs to be passed today to avoid a ...
Reports that cows have been infected despite farmers' preventive measures indicate there are multiple routes of transmission ...
The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The treatment, called CagriSema, led patients to lose 20% of their weight at 68 weeks in a late-stage study when looking at ...
New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
The updated definition allows more food to qualify as healthy, including higher fat fish, nuts, seeds, and certain oils.
The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put ...
People are increasingly turning to chatbots for help. But AIs struggle to detect violent or suicidal intentions.